Strategic Sale: Catherine Szyman Decides To Exercise Options Worth $2.32M At Edwards Lifesciences – Edwar – Benzinga

0
120

Strategic Sale: Catherine Szyman Decides To Train Choices Price $2.32M At Edwards Lifesciences – Edwar  Benzinga